维普中文期刊产品整合服务
20篇 您的检索式:作者名="Pierre Chan"
    题名 作者 年代 出处 被引量
1Evolution of systemic therapy of advanced hepatocellular carcinoma显示文摘Hepatocellular carcinoma (HCC) commonly occurs in hepatitis B endemic areas, especially in Asian countries. HCC is highly refractory to cytotoxic chemotherapy. This resistance is partly related to its tumor biology, pharmacokinetic properties, and both intrinsic and acquired drug resistance. There is no convincing evidence thus far that systemic chemotherapy improves overall survival in advanced HCC patients. Other systemic approaches, such as hormonal therapy and immunotherapy, have also disappointing results. Recently, encouraging results have been shown in using sorafenib in the treatment of advanced HCC patients. In this review, we concisely summarize the evolution of developments in the systemic therapy of advanced HCC.Thomas Yau Pierre Chan Richard Epstein Ronnie T Poon 2008World Journal of Gastroenterology2008,14,42:23
2Consensus Guidelines for the Management of Postoperative Nausea and Vomiting显示文摘Tong J. Gan Pierre Diemunsch Ashraf S. Habib Anthony Kovac Peter Kranke Tricia A. Meyer Mehernoor Watcha Frances Chung Shane Angus Christian C. Apfel Sergio D. Bergese Keith A. Candiotti Matthew TV Chan Peter J. Davis Vallire D. Hooper Sandhya Lagoo-Deena 2014Anesthesia & Analgesia2014,,:2
3Long-Term Follow-up of Tibial Shaft Fractures Treated With Intramedullary Nailing显示文摘Kelly A Lefaivre Pierre Guy Holman Chan Piotr A Blachut 2008Journal of Orthopaedic Trauma2008,,8:1
4Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica显示文摘Kelvin Chan Debbie Shaw Monique S.J. Simmonds Christine J. Leon Qihe Xu Aiping Lu Ian Sutherland Svetlana Ignatova You-Ping Zhu Rob Verpoorte Elizabeth M. Williamson Pierre Duez 2012Journal of Ethnopharmacology2012,,3:1
5Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease显示文摘Thomas Yau Hilda Wong Pierre Chan T. J. Yao R. Pang T. T. Cheung S. T. Fan Ronnie T. Poon 2012Investigational New Drugs2012,,6:1
6Enteral glutamine infusion modulates ubiquitination of heat shock proteins, Grp-75 and Apg-2, in the human duodenal mucosa显示文摘Julien Bertrand Alexis Goichon Philippe Chan Saida Azhar Stéphane Lecleire Nathalie Donnadieu David Vaudry Anne-Fran?oise Cailleux Pierre Déchelotte Mo?se Co?ffier 2014Amino Acids2014,,4:1
7Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis显示文摘Pierre Blanchard Anne Lee Sophie Marguet Julie Leclercq Wai Tong Ng Jun Ma Anthony T C Chan Pei-Yu Huang Ellen Benhamou Guopei Zhu Daniel T T Chua Yong Chen Hai-Qiang Mai Dora L W Kwong Shie Lee Cheah James Moon Yuk Tung Kwan-Hwa Chi George Fountzilas Li 2015The Lancet Oncology2015,,:1
8Periprosthetic osteoly sis: characterizing the innate immune response to titanium wear-particles 显示文摘St Pierre CA Chan M Iwakura Y 2010J Orthop Res2010,28,:1
9Periprosthetic osteolysis : characterizing the innate immune response to titanium wear-particles 显示文摘St Pierre CA Chan M Iwakura Y 2010J Orthop Res2010,28,11:1
10Periprosthetic osteolysis : charaet - erizing the innate immune response to titanium wear - particles 显示文摘ST PIERRE C A CHAN M IWAKURA Y 2010J Orthop Res2010,28,11:1
11Periprosthetic osteolysis: characterizing the innate immune rsponse to titanium wear-particles 显示文摘St Pierre CA Chan M Iwakura Y 2010J Orthop Res2010,28,11:1
12A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma显示文摘Thomas Yau P. N. Cheng Pierre Chan William Chan Li Chen Jimmy Yuen Roberta Pang S. T. Fan Ronnie T. Poon 2013Investigational New Drugs2013,,1:1
13Secondary Tricuspid Regurgitation or Dilatation: Which Should Be the Criteria for Surgical Repair?显示文摘Gilles D. Dreyfus Pierre J. Corbi K.M. John Chan Toufan Bahrami 2005The Annals of Thoracic Surgery2005,,1:1
14The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis显示文摘Joanne Chiu Yuen Fong Tang Tzy‐Jyun Yao Ashley Wong Hilda Wong Roland Leung Pierre Chan Tan To Cheung Albert C. Chan Roberta Pang Sheung‐Tat Fan Ronnie Poon Thomas Yau 2012Cancer2012,,21:1
15Pharmacovigilance of herbal medicine显示文摘Debbie Shaw Ladds Graeme Duez Pierre Williamson Elizabeth Chan Kelvin 2012Journal of Ethnopharmacology2012,,3:1
16Management of advanced hepatocellular carcinoma in era of targed therapy显示文摘Thomas Yau Pierre Chan Richard Epstain 2009Liv er International2009,,:1
17Synthesis of biodiesel in column fixed - bed bioreactor using the fermented solid produced by Burkholderia cepacia LTEB11 显示文摘Thais Fabiana Chan Saluma b Pierre Vineneuveb Bruno Bareab et al 2010Process Biochemistry2010,45,:1
18Staffing multi-skill call centers via search methods and a performance approximation显示文摘Athanassios N. Avramidis Wyean Chan Pierre L’Ecuyer 2009IIE Transactions2009,,:1
19Colon cancer in a patient with underlying aplastic anemia: A clinical challenge显示文摘The association of gastrointestinal malignancy with aplastic anemia has rarely been reported in the literature. Although it is not clear whether there is any direct relationship between aplastic anemia and gastrointestinal cancers, a retrospective analysis did suggest the notion that patients with aplastic anemia might have a higher incidence of colorectal cancer. Here, we report the diagnostic and therapeutic challenges in managing a patient with aplastic anemia and advanced colorectal cancer. Early diagnosis is challenging due to overlapping symptomatology and clinical features, increased risk of diagnostic procedures, and confounding complications arising from aplastic anemia and its treatment. A high index of suspicion and multidisciplinary input are essential.Hilda Wong Pierre Chan Thomas Yau 2012World Journal of Clinical Oncology2012,3,2:0
20A Continuous Action Space Tree search for INverse desiGn (CASTING) framework for materials discovery显示文摘Material properties share an intrinsic relationship with their structural attributes,making inverse design approaches crucial for discovering new materials with desired functionalities.Reinforcement Learning(RL)approaches are emerging as powerful inverse design tools,often functioning in discrete action spaces.This constrains their application in materials design problems,which involve continuous search spaces.Here,we introduce an RL-based framework CASTING(Continuous Action Space Tree Search for inverse design),that employs a decision tree-based Monte Carlo Tree Search(MCTS)algorithm with continuous space adaptation through modified policies and sampling.Using representative examples like Silver(Ag)for metals,Carbon(C)for covalent systems,and multicomponent systems such as graphane,boron nitride,and complex correlated oxides,we showcase its accuracy,convergence speed,and scalability in materials discovery and design.Furthermore,with the inverse design of super-hard Carbon phases,we demonstrate CASTING’s utility in discovering metastable phases tailored to user-defined target properties and preferences.Suvo Banik Troy Loefller Sukriti Manna Henry Chan Srilok Srinivasan Pierre Darancet Alexander Hexemer Subramanian K.R.S.Sankaranarayanan 2023npj Computational Materials2023,,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费